A Note on Peptides by Shantanu Out of Singapore BPC 157: The peptide with big claims and scant evidence STAT FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette FDA takes first step in possible reversal of ban on some peptides The Washington Post